• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX INC. AFX; BIFURCATED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX INC. AFX; BIFURCATED Back to Search Results
Model Number BA28-100/I20-40
Device Problems Failure To Adhere Or Bond (1031); Hole In Material (1293); Leak/Splash (1354)
Patient Problems Aneurysm (1708); Failure of Implant (1924)
Event Date 12/01/2016
Event Type  Injury  
Manufacturer Narrative
The devices involved in the event will not be returned for evaluation, they remain implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.Devices remain implanted in the patient.
 
Event Description
It was reported the patient had an initial implant on (b)(6) 2013 with a bifurcated stent and suprarenal aortic extension.On (b)(6) 2015, the patient had a type 3b endoleak and the physician elected to reline with an additional bifurcated stent.On (b)(6) 2016 a follow up computed tomography (ct) showed a potential type 3a or type 3b endoleak.A subsequent endovascular procedure has not been scheduled at this time.There have been no additional adverse events reported for this patient.
 
Manufacturer Narrative
At the completion of the complaint investigation, based on the information received, the clinical evaluation was able to confirm the reported type 3b endoleak of the proximal extension, a persistent type 3b endoleak of the main body and a type 3a endoleak.The clinical evaluation additionally found evidence to reasonably suggest the following contributing factors to the reported event; off label use, untreated endoleak type iiib of the cuff, and poor stent to stent apposition.The review of manufacturing lot confirmed all devices met specifications prior to release.The event devices have not been returned and were not available for further evaluation.The root cause of the reported event is unknown.There is not enough information to determine the root cause of the reported event at this time.To date there has been no additional information on the current patient status.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
BIFURCATED
Manufacturer (Section D)
ENDOLOGIX INC.
2 musick
irvine CA 92618
Manufacturer Contact
tahereh sedighi
2 musick
irvine, CA 92618
9495984671
MDR Report Key6216907
MDR Text Key63687769
Report Number2031527-2016-00603
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00818009014207
UDI-Public(01)00818009014207(17)180602
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/27/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/02/2018
Device Model NumberBA28-100/I20-40
Device Lot Number1346832-002
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/01/2016
Initial Date FDA Received12/31/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received03/23/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/16/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
AORTO UNI-ILIAC [SUPRARENAL]- (B)(4); BIFURCATED- (B)(4)
Patient Outcome(s) Required Intervention;
Patient Age68 YR
-
-